India has launched generic semaglutide, paving the way for more affordable and accessible treatments for diabetes and weight loss. This game-changing development marks a significant turning point in the market, aligning with thrilling global progress in obesity therapies
The Wegovy weight loss pill, already approved in the U.S. for treating obesity, is on the verge of launching in Canada. As Health Canada reviews this promising medication, many are eagerly anticipating fresh and effective options for weight management coming soon!
Eli Lilly’s recent launch of Mounjaro in India has sparked a surge in inquiries about weight-loss solutions. The new drug, aimed at managing obesity, has captured significant attention, reflecting a growing demand for effective weight management options in the country.
